Marta María
Alonso Roldán
Profesional Investigadora
![Foto de Marta María](/img/nophoto.png)
![Foto de Clínica Universitaria de Navarra](/img/noimage_org.png)
Clínica Universitaria de Navarra
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Clínica Universitaria de Navarra (37)
2022
-
Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas
JCI Insight, Vol. 7, Núm. 7
-
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
New England Journal of Medicine, Vol. 386, Núm. 26, pp. 2471-2481
-
The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
Neuro-oncology, Vol. 24, Núm. 9, pp. 1408-1422
2021
-
Clinical value of NGS genomic studies for clinical management of pediatric and young adult bone sarcomas
Cancers, Vol. 13, Núm. 21
-
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 4
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
-
Hitchhiking to brain tumours: stem cell delivery of oncolytic viruses
The Lancet Oncology
2020
-
Somatic and germline analysis of a familial Rothmund–Thomson syndrome in two siblings with osteosarcoma
npj Genomic Medicine, Vol. 5, Núm. 1
2019
-
Destress and do not suppress: Targeting adrenergic signaling in tumor immunosuppression
Journal of Clinical Investigation, Vol. 129, Núm. 12, pp. 5086-5088
-
Localized treatment with oncolytic adenovirus delta-24-RGDOX induces systemic immunity against disseminated subcutaneous and intracranial melanomas
Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6801-6814
-
Oncolytic adenovirus Delta-24-RGD induces a widespread glioma proteotype remodeling during autophagy
Journal of Proteomics, Vol. 194, pp. 168-178
-
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
Scientific Reports, Vol. 9, Núm. 1
2018
-
Basic and Translational Advances in Glioblastoma
BioMed Research International
-
DNX-2401, an oncolytic virus, for the treatment of newly diagnosed diffuse intrinsic pontine gliomas: A case report
Frontiers in Oncology, Vol. 8, Núm. MAR
-
Heterogeneity within the PF-EPN-B ependymoma subgroup
Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237
-
Intratumoral injection of activated B lymphoblast in combination with PD-1 blockade induces systemic antitumor immunity with reduction of local and distal tumors
OncoImmunology, Vol. 7, Núm. 8
-
Linking inflammation and cancer: The unexpected SYK world
Neuro-Oncology
-
Oncolytic virotherapy for gliomas: A preclinical and clinical summary
Gene Therapy in Neurological Disorders (Elsevier), pp. 357-384
-
Oncolytic viruses as therapeutic tools for pediatric brain tumors
Cancers, Vol. 10, Núm. 7
-
Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection
Oncotarget, Vol. 9, Núm. 57, pp. 31045-31065